Research and development strategies of new Chinese medicines based on new regulations / 中国中药杂志
China Journal of Chinese Materia Medica
;
(24): 3150-3155, 2021.
Artigo
em Chinês
| WPRIM
| ID: wpr-888055
ABSTRACT
In recent years, only a small number of new Chinese medicines have been approved for marketing, which has embodied the bottleneck in the development of the Chinese medicine industry. To tackle this problem, the National Medical Products Administration has issued a series of regulations and technical requirements. In the context of new regulations, this study deeply explored the research and development strategies of new Chinese medicines under the guidance of the new classification of drug registration, and discussed the key technical issues in the research and development.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Pesquisa
/
Medicamentos de Ervas Chinesas
/
Preparações Farmacêuticas
/
China
/
Medicina Tradicional Chinesa
Tipo de estudo:
Estudo diagnóstico
País/Região como assunto:
Ásia
Idioma:
Chinês
Revista:
China Journal of Chinese Materia Medica
Ano de publicação:
2021
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS